Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Medicines With The Active Ingredient Denosumab (atc 2025-11-17
Lithuania Medical And Other Gas Orders Via The Cpo Lt Electronic Catalog 2025-11-17
Germany Open House Pharmaceutical Discounts On The Active Ingredient Denosumab, Trade Name Prolia, Atc M05bx04 2025-11-17
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Fusidic Acid, Atc D06ax01 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-17
Germany Open House Medicinal Practice Treaties For The Active Ingredient Pegintereron Alfa2a, Atc L03ab11 2025-11-17
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lanreotide, Atc H01cb03 For The Time 01.07.2025 30.06.2026 (plus Extension Option 1x 12 Months) 2025-11-17
Germany Open House Pharmaceutical Discounts On The Active Ingredient Acitretin, Atc D05bb02 2025-11-17
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Somatropin, Atc H01ac01 For The Time 01.07.2025 30.06.2027 2025-11-17
United States Technology Transfer Licensing Opportunity: Diagnostic Kit To Detect Human Infertility 2025-11-17
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Cabotegravir, Atc J05aj04 For The Time 01.07.2025 30.06.2027 2025-11-17
Whats app